Wed, 26 Oct 2016 22:29:24 GMT
Allergan CEO Brent Saunders Succeeds Paul Bisaro as Chairman
- Wall Street Journal
Allergan PLC named Chief Executive Brent Saunders to the additional post of chairman, succeeding Paul Bisaro. Mr. Bisaro was chief executive from 2007 through 2014, and has since served as executive chairman. He will remain on the board.
Wed, 26 Oct 2016 21:53:05 GMT
Allergan's Saunders Adds Chairman Role
- Orange County Business Journal
Saunders has been president and chief executive since July 2014, when the company, then called Actavis Plc, bought Forest Laboratories
Inc. in New York, where Saunders had held the same roles. Bisaro was president, chief executive and chairman of ...
Thu, 20 Oct 2016 18:22:52 GMT
Mon, 26 Sep 2016 22:20:17 GMT
Judge Orders Depositions Of Ex-Forest Labs Employees
- Law360 (subscription)
Law360, New York (September 26, 2016, 5:47 PM EDT) -- A Boston federal judge has granted a motion to compel six new depositions of former Forest Laboratories
Inc. officials in a suit over the effectiveness of Celexa and Lexapro in children, but also ...
Fri, 02 Sep 2016 04:32:31 GMT
Wed, 31 Aug 2016 15:45:16 GMT
Wed, 31 Aug 2016 12:30:16 GMT
Wed, 31 Aug 2016 12:07:43 GMT
Sun, 28 Aug 2016 18:01:14 GMT
Allergan: An Undervalued Powerhouse
In 2014, the company acquired Forest Laboratories
for $25 billion. Forest Laboratories
was considered a good fit for Allergan due to its strong legacy in branded specialty and primary care pharmaceuticals. In the same year, Actavis and Allergan decided ...
Fri, 29 Jul 2016 01:30:31 GMT
Mayne Pharma Group settles patent infringement case
- Finance News Network
Mayne Pharma Group Limited (ASX:MYX) has announced it has entered into a settlement agreement with Forest Laboratories
. The settlement relates to a patent infringement lawsuit Mayne Pharma filed against Forest in December 2013 regarding Forest's ...